Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

MS research suggests the disease may be divided into two biological subtypes that differ in how early and aggressively nerve ...

Many people with multiple sclerosis struggle with balance and coordination, and this study uncovers a hidden reason why.

There may be two distinct subtypes of multiple sclerosis, according to a new study led by scientists at University College ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

New research suggests that balance and coordination problems in multiple sclerosis may begin when key brain cells slowly run ...

The FDA has granted breakthrough therapy designation to privosegtor for optic neuritis, a common symptom of multiple ...

Artificial intelligence (AI), using a simple blood test combined with standard brain images has, for the first time, been ...

NICE has recommended the drug, natalizumab, as an option for adults with relapsing-remitting MS (RRMS) that remains highly active after a full course of at least one disease-modifying therapy, and for ...

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...

Increasing evidence suggests that the severe gum disease, periodontitis, may contribute to central nervous system disorders ...